tisagenlecleucel,axicabtagene ciloleucel
gilead,novartis
['lymsm', 'pcnsl', 'tisacel']
french experience of car-t in r/r pcnsl #17icml
- 25 pts, most tisacel
- 60% cr, 1-yr pfs 41%
- responses better if cr prior to car-t
- high grade crs 8%, icans 20%
query differences by costim domain? good responses in poor prognostic setting. #lymsm #celltherapy 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈